Expression of DNA-dependent protein kinase in human granulocytes

Annahita Sallmyr1, Anna Miller, Aida Gabdoulkhakova

  • 1Department of Medical Microbiology, Lund University, Malmo University Hospital, S-205 02 Malmo, Sweden.

Cell Research
|September 9, 2004
PubMed

Insights

Human polymorphonuclear leukocytes (PMN) have reduced DNA-dependent protein kinase (DNA-PK) expression, not a complete absence, during myeloid differentiation. This finding corrects previous assumptions about DNA repair mechanisms in mature white blood cells.

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Immunology

Background:

  • Human polymorphonuclear leukocytes (PMN) were previously thought to lack DNA-dependent protein kinase (DNA-PK), crucial for DNA repair.
  • Promyelocytic HL-60 cells exhibit a variant Ku protein, leading to increased radiation sensitivity.
  • This raised questions about the efficiency of nonhomologous end-joining (NHEJ) in myeloid differentiation.

Purpose of the Study:

  • To investigate the expression and integrity of DNA-PK in human PMN and HL-60 cells.
  • To determine if the previously reported absence of DNA-PK in PMN is accurate.
  • To clarify the role of DNA-PK in myeloid differentiation and DNA repair.

Main Methods:

  • Analysis of DNA-PK and Ku protein expression in PMN and HL-60 cell extracts.
  • Investigation of a potential DNA-PK-degrading protease in these cells.
  • Utilization of a protease-resistant whole cell assay to detect intact DNA-PK components.

Main Results:

  • Confirmed the absence of intact DNA-PK in PMN protein extracts and the presence of a truncated Ku86 variant in HL-60 cells.
  • Identified a DNA-PK-degrading protease in both PMN and HL-60 cells.
  • Demonstrated the presence of Ku86 and DNA-PKcs in PMN using a protease-resistant assay, indicating reduced, not absent, expression.
  • Observed significantly lower levels of Ku86 and DNA-PKcs in PMN compared to lymphocytes, and elevated levels in HL-60 cells.

Conclusions:

  • The absence of DNA-PK in human PMN is an artifact caused by a protease.
  • Mature myeloid differentiation is characterized by reduced, rather than depleted, DNA-PK expression.
  • These findings have implications for understanding DNA repair efficiency during myeloid cell maturation.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Exon Recombination02:32

Exon Recombination

The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes. 
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...